139 related articles for article (PubMed ID: 9128318)
21. Effect of plaunotol in combination with clarithromycin against clarithromycin-resistant Helicobacter pylori in vitro and in vivo.
Sasaki M; Mizoshita T; Mizushima T; Inoue H; Kamiya T; Kataoka H; Ogaswara N; Wada T; Kubota E; Mori Y; Shimura T; Hirata H; Ando K; Okamoto Y; Ohara H; Nakao H; Joh T
J Antimicrob Chemother; 2007 Nov; 60(5):1060-3. PubMed ID: 17827146
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological therapy of Helicobacter pylori infection.
Hoffman JS
Semin Gastrointest Dis; 1997 Jul; 8(3):156-63. PubMed ID: 9232728
[TBL] [Abstract][Full Text] [Related]
23. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
[TBL] [Abstract][Full Text] [Related]
24. [Influence of resistance of Helicobacter pylori to antibiotics on the Helicobacter pylori eradication regimens].
Cheng H; Hu FL; Li J
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(38):2679-82. PubMed ID: 17199976
[TBL] [Abstract][Full Text] [Related]
25. [Helicobacter pylori antibiotic sensitivity by microdilution].
Rivas F; Rivera P; Hernández F; Hevia F; Guillén F; Tamayo G
Rev Med Panama; 2000; 25():19-23. PubMed ID: 15881743
[TBL] [Abstract][Full Text] [Related]
26. [In vitro activity of clarithromycin and metronidazole against Helicobacter pylori in different incubation atmospheres].
Alarcón T; Domingo D; Prieto N; de la Obra P; López-Brea M
Rev Esp Quimioter; 2002 Dec; 15(4):341-5. PubMed ID: 12587039
[TBL] [Abstract][Full Text] [Related]
27. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
[TBL] [Abstract][Full Text] [Related]
28. In vitro and in vivo anti-Helicobacter/Campylobacter activity of the aqueous extract of Enantia chlorantha.
Tan PV; Boda M; Etoa FX
Pharm Biol; 2010 Mar; 48(3):349-56. PubMed ID: 20645825
[TBL] [Abstract][Full Text] [Related]
29. In vitro anti-Helicobacter pylori activity of ebrotidine.
Palacín C; Tarragó C; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):471-4. PubMed ID: 9205746
[TBL] [Abstract][Full Text] [Related]
30. Susceptibility of Helicobacter pylori to antimicrobial agents: effect of ebrotidine and ranitidine.
Piotrowski J; Piotrowski E; Slomiany A; Slomiany BL
J Physiol Pharmacol; 1995 Dec; 46(4):463-9. PubMed ID: 8770790
[TBL] [Abstract][Full Text] [Related]
31. Anti-unlcer and antimicrobial activities of sodium selenite against Helicobacter pylori: in vitro and in vivo evaluation.
Kumar BS; Tiwari SK; Manoj G; Kunwar A; Amrita N; Sivaram G; Abid Z; Ahmad A; Khan AA; Priyadarsini KI
Scand J Infect Dis; 2010 Apr; 42(4):266-74. PubMed ID: 20092379
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of Helicobacter pylori colonization by an antiulcer agent, sulglycotide.
Czajkowski A; Piotrowski J; Yotsumoto F; Slomiany A; Slomiany BL
Biochem Mol Biol Int; 1993 Apr; 29(5):965-71. PubMed ID: 8508147
[TBL] [Abstract][Full Text] [Related]
33. Mechanochemical synthesis and in vitro anti-Helicobacter pylori and uresase inhibitory activities of novel zinc(II)-famotidine complex.
Amin M; Iqbal MS; Hughes RW; Khan SA; Reynolds PA; Enne VI; Sajjad-ur-Rahman ; Mirza AS
J Enzyme Inhib Med Chem; 2010 Jun; 25(3):383-90. PubMed ID: 19857049
[TBL] [Abstract][Full Text] [Related]
34. In vitro anti-Helicobacter pylori activity of irisolidone isolated from the flowers and rhizomes of Pueraria thunbergiana.
Bae EA; Han MJ; Kim DH
Planta Med; 2001 Mar; 67(2):161-3. PubMed ID: 11301866
[TBL] [Abstract][Full Text] [Related]
35. Individual and combined effects of foods on Helicobacter pylori growth.
Keenan JI; Salm N; Hampton MB; Wallace AJ
Phytother Res; 2010 Aug; 24(8):1229-33. PubMed ID: 20658571
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory activities of lansoprazole against respiration in Helicobacter pylori.
Nagata K; Sone N; Tamura T
Antimicrob Agents Chemother; 2001 May; 45(5):1522-7. PubMed ID: 11302821
[TBL] [Abstract][Full Text] [Related]
37. Interference on Helicobacter pylori growth and adhesion by omeprazole and other drugs.
Gismondo MR; Drago L; Lombardi A; Fassina MC; Mombelli B
J Chemother; 1998 Jun; 10(3):225-30. PubMed ID: 9669648
[TBL] [Abstract][Full Text] [Related]
38. Helicobacter pylori: in vitro induction of resistance to azithromycin.
Kalenić S; Plecko V; Kresić S; Presecki V; Tripković V; Zele-Stracević L; Katicić M; Dominis M
Chemotherapy; 1998; 44(1):17-20. PubMed ID: 9444404
[TBL] [Abstract][Full Text] [Related]
39. [In vitro activity of 16 antimicrobial agents against Helicobacter (Campylobacter) pylori].
García-Rodríguez JA; García-García MI; García-Sánchez E; García-Sánchez JE; Muñoz Bellido JL
Enferm Infecc Microbiol Clin; 1989 Dec; 7(10):544-6. PubMed ID: 2490433
[TBL] [Abstract][Full Text] [Related]
40. Comparative evaluation of agar dilution and broth microdilution methods for antibiotic susceptibility testing of Helicobacter cinaedi.
Tomida J; Oumi A; Okamoto T; Morita Y; Okayama A; Misawa N; Hayashi T; Akaike T; Kawamura Y
Microbiol Immunol; 2013 May; 57(5):353-8. PubMed ID: 23668607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
